206 related articles for article (PubMed ID: 6244234)
1. NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV.
Fresen KO; Cho MS; Gissmann L; zur Hausen H
Intervirology; 1980; 12(6):303-10. PubMed ID: 6244234
[TBL] [Abstract][Full Text] [Related]
2. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
[TBL] [Abstract][Full Text] [Related]
3. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.
Cho MS; Fresen KO; zur Hausen H
Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006
[TBL] [Abstract][Full Text] [Related]
4. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained.
Reisman D; Sugden B
Virology; 1984 Aug; 137(1):113-26. PubMed ID: 6089410
[TBL] [Abstract][Full Text] [Related]
5. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
Stoerker J; Yajima Y; Glaser R
Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
Cho MS; Gissmann L; Hayward SD
Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
8. Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells.
Cho MS; Bornkamm GW; zur Hausen H
J Virol; 1984 Jul; 51(1):199-207. PubMed ID: 6328039
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome.
Sato H; Takimoto T; Hatano M; Pagano JS; Raab-Traub N
J Gen Virol; 1989 Mar; 70 ( Pt 3)():717-27. PubMed ID: 2543756
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus with heterogeneous DNA disrupts latency.
Miller G; Rabson M; Heston L
J Virol; 1984 Apr; 50(1):174-82. PubMed ID: 6321789
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus recombinants from overlapping cosmid fragments.
Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
[TBL] [Abstract][Full Text] [Related]
12. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
Dambaugh T; Hennessy K; Chamnankit L; Kieff E
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7632-6. PubMed ID: 6209719
[TBL] [Abstract][Full Text] [Related]
13. Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.
Sato H; Takimoto T; Pagano JS; Raab-Traub N
J Virol; 1988 Sep; 62(9):3288-94. PubMed ID: 2841481
[TBL] [Abstract][Full Text] [Related]
14. Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells.
Yano S; Tanaka A; Takada K; Fujiwara S; Osato T; Nonoyama M
Virology; 1982 Jun; 119(2):392-8. PubMed ID: 6281981
[No Abstract] [Full Text] [Related]
15. [Structural organization of the Epstein-Barr virus genome].
D'iachenko AG
Eksp Onkol; 1984; 6(4):3-10. PubMed ID: 6209094
[TBL] [Abstract][Full Text] [Related]
16. Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.
Jenson HB; Rabson MS; Miller G
J Virol; 1986 May; 58(2):475-86. PubMed ID: 3009861
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.
Bornkamm GW; Delius H; Zimber U; Hudewentz J; Epstein MA
J Virol; 1980 Sep; 35(3):603-18. PubMed ID: 6252328
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion.
King W; Dambaugh T; Heller M; Dowling J; Kieff E
J Virol; 1982 Sep; 43(3):979-86. PubMed ID: 6292475
[TBL] [Abstract][Full Text] [Related]
19. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
Traul KA; Stephens R; Gerber P; Peterson WD
Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
[TBL] [Abstract][Full Text] [Related]
20. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
